Peel Therapeutics to Present Data on its TOP1 Inhibitor PEEL-224 at the Connective Tissue Oncology Society Annual Meeting and Society for Immunotherapy of Cancer...
SALT LAKE CITY, Nov. 1, 2023 /PRNewswire/ -- Peel Therapeutics, a clinical stage biotech company developing evolutionary based medicines, will present data on its lead clinical ass…
